News
FDA approves first twice-a-year and cost-effective HIV prevention shot
The Food and Drug Administration approved a new vaccine to prevent HIV infection, lenacapavir, a long-acting injection, which is only required to be taken twice a year.The drug showed nearly 100% effectiveness in clinical trials.
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback